Monoxerutin API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Monoxerutin API 23869-24-1?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Monoxerutin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Monoxerutin
- Synonyms:
- beta-Hydroxyethylrutosid , Mono-7-hydroxyethylrutoside , Monoxerutina , Monoxerutine , Monoxerutinum , O-(beta-Hydroxyethyl)rutin
- Cas Number:
- 23869-24-1
- DrugBank number:
- DB13764
- Unique Ingredient Identifier:
- EKF7043SBU
General Description:
Monoxerutin, identified by CAS number 23869-24-1, is a notable compound with significant therapeutic applications. Monoxerutin is a flavonol, a type of flavonoid.
Classification:
Monoxerutin belongs to the class of organic compounds known as flavonoid-3-o-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position, classified under the direct parent group Flavonoid-3-O-glycosides. This compound is a part of the Organic compounds, falling under the Phenylpropanoids and polyketides superclass, and categorized within the Flavonoids class, specifically within the Flavonoid glycosides subclass.
Categories:
Monoxerutin is categorized under the following therapeutic classes: Capillary Stabilizing Agents, Flavonoids, Vasoprotectives. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Monoxerutin is a type of Antioxidants
Antioxidants are a vital category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a crucial role in preventing oxidative damage and promoting overall health. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body's antioxidant defense mechanisms.
Antioxidants function by neutralizing ROS and minimizing the potential harm they can cause to cells and tissues. This category includes a diverse range of compounds, such as vitamins (e.
g.
, vitamin C, vitamin E), minerals (e.
g.
, selenium, zinc), and phytochemicals (e.
g.
, polyphenols, flavonoids). These antioxidants can be obtained from natural sources like fruits, vegetables, and herbs, or they can be synthesized in laboratories for pharmaceutical use.
The role of antioxidants in the prevention and treatment of various diseases has been extensively studied. They have demonstrated the ability to reduce the risk of chronic diseases like cardiovascular disorders, cancer, and neurodegenerative conditions. Moreover, antioxidants exhibit anti-inflammatory properties, enhance immune function, and protect against age-related damage.
In the pharmaceutical industry, antioxidants are widely utilized as key ingredients in the formulation of drugs, dietary supplements, and cosmetic products. They contribute to the stability and shelf life of pharmaceutical preparations by preventing oxidative degradation. Antioxidant APIs are manufactured with strict quality control measures to ensure purity, efficacy, and safety.
In conclusion, antioxidants are essential pharmaceutical APIs that provide numerous health benefits. Their ability to counteract oxidative stress and protect cells from damage makes them a valuable component in the prevention and treatment of various diseases. The pharmaceutical industry relies on these antioxidants to enhance the quality and efficacy of their products, making them indispensable in the field of healthcare.
